How MEIS Genes Affect Neural Stem Cells and Restless Legs Syndrome
Author Information
Author(s): Volker Kittke, Chen Zhao, Daniel D. Lam, Philip Harrer, Wojciech Krezel, Barbara Schormair, Konrad Oexle, Juliane Winkelmann
Primary Institution: Helmholtz Munich
Hypothesis
MEIS1 and MEIS2 control distinct processes in human neural stem cells and their roles in restless legs syndrome (RLS) have not been systematically compared.
Conclusion
The study found that MEIS1 and MEIS2 regulate different sets of target genes and biological processes in human neural stem cells, with MEIS1 being linked to RLS-associated genes.
Supporting Evidence
- MEIS1 and MEIS2 were found to control distinct sets of target genes.
- MEIS1 was linked to RLS-associated genes NTNG1, MDGA1, and DACH1.
- The study utilized CRISPR/Cas9 for gene manipulation in human neural stem cells.
Takeaway
Scientists studied two genes, MEIS1 and MEIS2, to see how they help brain cells grow and how they might be connected to a leg problem called restless legs syndrome.
Methodology
The study used CRISPR/Cas9 to knockout and overexpress MEIS1 and MEIS2 in human neural stem cells, followed by RNA sequencing to analyze gene expression.
Limitations
The study is limited to examining direct transcriptional effects of MEIS dysregulation and does not account for long-term effects.
Participant Demographics
Human neural stem cells were used, but specific demographic details were not provided.
Statistical Information
P-Value
4.8*10−18
Confidence Interval
[23.7–93.2]
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website